FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...